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Background. The risk for developing a periprosthetic joint infection (PJI) during bacteremia is unclear, except for Staphylococcus 
aureus bacteremia. The aim of this study was to examine the risk for developing a PJI during bacteremia and to identify possible risk 
factors leading to it.
Methods. Patients with a primary knee or hip joint replacement performed in a tertiary care hospital between September 2002 
and December 2013 were identified (n = 14 378) and followed up until December 2014. Positive blood culture results during the 
study period and PJIs were recorded. PJIs associated with an episode of bacteremia were identified and confirmed from patient 
records. Potential risk factors for PJI among those with bacteremia were examined using univariate logistic regression.
Results. A total of 542 (3.8%) patients had at least 1 episode of bacteremia. Seven percent (47/643) of the bacteremias resulted 
in a PJI. Development of a PJI was most common for Staphylococcus aureus (21% of bacteremias led to a PJI) and beta-hemolytic 
streptococci (21%), whereas it was rare for gram-negative bacteria (1.3%). Having ≥2 bacteremias during the study period increased 
the risk for developing a PJI (odds ratio, 2.29; 95% confidence interval, 1.17–4.50). The risk for developing a PJI was highest for 
bacteremias occurring within a year of previous surgery. Chronic comorbidities did not affect the risk for PJI during bacteremia.
Conclusions. The development of a PJI during bacteremia depends on the pathogen causing the bacteremia and the timing of 
bacteremia with respect to previous joint replacement surgery. However, significant patient-related risk factors for PJI during bac-
teremia could not be found.
Keywords. bacteremia; prosthetic joint infection; risk factors; Staphylococcus aureus; streptococci.
Hematogenous periprosthetic joint infections (PJIs) are due 
to hematogenous spread from another infection site and can 
occur at any time after joint replacement surgery [1, 2]. Late 
PJIs are usually hematogenous, but there is no consensus on 
the definition of late PJI. According to the traditional defi-
nition by Coventry et  al., they occur 2  years after surgery or 
later [3]. However, other studies have used time limits from 
3 [4] to 12 months [5]. Late acute PJIs are also characterized 
by an asymptomatic postoperative period before the onset of 
symptoms of infection. The proportion of late hematogenous 
PJIs has been estimated to be 13%–27% of all PJIs [6–10], 
whereas the overall incidence of late PJIs is around 0.25%–0.7% 
[5, 6, 8, 9, 11, 12] or 0.069% per prosthesis-year [10].
The origin of hematogenous PJIs can be from the skin and 
soft tissues, urinary tract, dental sources [4, 5], cardiovas-
cular system [13], lungs [11], or the gastrointestinal tract [14]. 
Although most PJIs are caused by either coagulase-negative 
staphylococci or Staphylococcus aureus, hematogenous PJIs 
are mostly caused by S.  aureus, followed by streptococci and 
gram-negative bacteria [1, 2, 15–17].
According to previous studies, 25%–40% of patients with 
Staphylococcus aureus bacteremia (SAB) and a joint replace-
ment develop a hematogenous PJI [18–22]. The presence of 3 
or more joint replacements increased the risk for PJI consid-
erably during SAB in 1 study [21], but other studies have not 
been able to show patient-related risk factors for developing a 
PJI during SAB [20]. The risk for developing a PJI during bacte-
remia caused by other pathogens is unclear, as most reports on 
PJIs during bacteremia have been case studies [23–26]. Uçkay 
et al. reported a PJI rate of 6% in patients with any bacteremia 
[14]. Risk factors for developing a PJI during any bacteremia 
have not been studied.
The aim of this study was to examine the risk for developing 
a PJI during bacteremia caused by different pathogens and to 
identify possible risk factors leading to it.
METHODS
This is a retrospective study that was performed at the Coxa 
Hospital for Joint Replacement, Tampere, Finland. Patients 
from Pirkanmaa Hospital District (population ca. 500  000 
inhabitants) who had a primary knee or hip replacement 
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performed between September 2002 and December 2013 at the 
hospital were identified from the hospital database (see Figure 
1 for a description of the study patients). Patients could have 
had additional primary hip and knee replacements (performed 
elsewhere or before the study period), but information on these 
was not available. The follow-up period for each patient was 
from the date of the first joint replacement surgery during the 
study period to the date of death or December 31, 2014, which-
ever occurred first. According to national legislation, patient in-
formed consent was not required due to the retrospective design 
of the study. Institutional permission to conduct this study was 
granted by the authorities responsible for the patient records.
All positive blood culture results of the study patients 
occurring after the primary surgery until December 31, 
2014, were obtained from the electronic records of the ac-
credited microbiology laboratory of Tampere University 
Hospital. Positive blood cultures caused by coagulase-negative 
staphylococci, corynebacteria, micrococci, or Cutibacterium 
species were considered significant only if there was growth 
on 2 blood culture bottles (n = 28); otherwise, they were de-
fined as contaminants (n  =  89). Positive blood cultures by 
other pathogens were considered significant regardless of the 
number of positive culture bottles. All consecutive positive 
blood cultures with the same organism taken within 7 days of 
the first positive sample were considered part of the same epi-
sode of bacteremia.
PJI cases were identified from 6 different data sources: 
(1) prospective surveillance data from the national Finnish 
Hospital Infection Program of the National Institute of Health 
and Welfare, (2) postdischarge surveillance data gathered by 
an infection control nurse, (3) positive bacterial cultures of 
joint aspirates or tissue cultures from samples taken at the 
Coxa Hospital for Joint Replacement, (4) hospital discharge 
records with a diagnosis code of PJI (ICD-10 diagnosis code 
T84.5 or T81.4), (5) local joint replacement database records 
on revision arthroplasties performed due to PJI, and (6) Coxa’s 
own infection register. A  detailed description of these data 
sources can be found in a previous study of the patient pop-
ulation [27]. If the PJI occurred in a joint that was replaced 
outside of the study period (n = 4), it was not included in the 
analyses (but the patients remained in the study cohort, as 
they had other joints replaced at the Coxa hospital during the 
study period).
Patients with the same organism cultured from blood and 
from the affected joint were considered to have a PJI as a 
consequence of bacteremia. Cases where the PJI was deter-
mined to be the source of the bacteremia, based on the timing 
of symptom onset, were identified from the patient charts 
(n  =  9) by 1 of the authors (M.H.) and were not included 
in the analyses. If the patient had a culture-negative PJI and 
bacteremia, patient charts were also reviewed. If the treating 
clinicians considered the PJI to be caused by the pathogen 
identified in the blood culture, it was recorded as such. Also, 
patient charts of patients who had a long duration (>7 days) 
between the positive blood culture and identification of the 
PJI were checked to verify the association.
Information on patients’ chronic diseases (diabetes, rheu-
matic diseases, chronic heart failure, chronic coronary disease, 
arrhythmias, and chronic lung disease) was gathered from the 
drug reimbursement register of the Social Insurance Institution 
of Finland. For the statistical analyses, chronic heart failure, 
chronic coronary disease, and arrhythmias were grouped to-
gether (chronic heart disease). Information on body mass 
index (BMI), indication for joint replacement surgery, use of 
(antibiotic-impregnated) cement in the surgery, and date of 
death was gathered from Coxa’s electronic database.
14 378 patients with a
primary knee or hip
joint replacement in
the Coxa hospital
13 747 patients with no bacteremia
631 patients with a
positive blood culture
89 patients with only contaminants in the
blood culture(s)
542 patients with
significant bacteremias
467 patients with bacteremia, but no PJI
17 patients with a PJI not associated with
bacteremia
9 patients with bacteremia due to a primary
PJI
4 patients with a PJI during bacteremia in a
joint operated in another hospital
45 patients with a PJI (in a joint operated in
the Coxa hospital) during an episode of
bacteremia
Figure 1. Description of the study patients. Abbreviation: PJI, periprosthetic joint 
infection.
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Statistical Analysis
All data analyses and management were performed using the 
SPSS for Windows 25.0 statistical software package.
The incidence of bacteremia and PJI was calculated as the in-
cidence rate per 1000 person-years. Incidence of PJI as a con-
sequence of bacteremias caused by different pathogens was 
calculated. Means or medians were calculated for continuous 
variables with a normal or skewed distribution, respectively.
The association between different potential risk factors 
(number of bacteremias, BMI, male gender, knee location, 
time since previous joint replacement surgery, age, indication 
for joint replacement surgery, use of cement in the operation, 
and chronic diseases) and the development of a PJI during bac-
teremia were examined for each joint separately. If the patient 
had multiple bacteremias during the study period, each was in-
cluded in the analyses separately when analyzing the effect of 
age and time since previous joint replacement surgery on the 
risk for PJI. Potential risk factors were analyzed using binary 
logistic regression with univariate analysis, and odds ratios and 
95% confidence intervals were calculated.
RESULTS
There were 14 378 patients with a primary knee or hip joint re-
placement performed during the study period. Of these, 4475 
patients had more than 1 primary joint replacement. A  total 
of 1346 patients had a revision arthroplasty performed during 
the study period. The mean follow-up time (range) was 6.0 
(0–12) years.
During the study period, 542 (3.8%) patients had at least 1 ep-
isode of bacteremia after the primary joint replacement surgery, 
and 85 (0.6%) patients had more than 1 bacteremia. The max-
imum number of separate episodes of bacteremia per patient 
was 8 (1 patient). In total, there were 643 episodes of bacteremia. 
The incidence rate of bacteremia was 7.4 per 1000 person-years. 
The bacteremias occurred 3–4285 days after the first joint re-
placement operation (median, 1460 days); 13% occurred within 
1 year (85/643) and 4% within 3 months (27/643). Escherichia 
coli was the most common causative pathogen (241/643, 37% 
of bacteremias). The distribution of pathogens causing the 
bacteremias is shown in Table 1.
There were in total 288 PJIs, and the incidence rate was 
3.3 per 1000 person-years. Of the infections, 131 (45%) were 
early infections occurring within 90 days of the previous sur-
gery, 53 (18%) occurred within 3–12 months, and 104 (36%) 
occurred after 1 year. The distributions of the PJIs over time 
for patients with and without bacteremia are shown in Figure 
2A and B.
Of the episodes of bacteremia, 7% (46/643) resulted in a 
PJI (Table 1). One of these was a bilateral knee infection. Of 
the PJIs during bacteremia, 29 (62%) were in the knees and 
18 (38%) in the hips. Seven PJIs occurred after revision joint 
replacement. One patient had 2 separate PJIs associated with 
different episodes of bacteremia. Thus, 45/542 (8%) patients 
with 1 or more episodes of bacteremia developed a PJI. The du-
ration between the first positive blood culture and identification 
of the PJI ranged from 0 to 512 days (median, 2 days). There 
were 10 (21%) PJIs where the pathogen could not be identified 
from the affected joint, but these were considered to be caused 
by the pathogen identified in the blood culture. In most cases, 
these patients had received antibiotics before taking the samples 
for bacterial culture from the joint.
The development of a PJI during bacteremia varied be-
tween different pathogens (Table 1). It was most common for 
Staphylococcus aureus, beta-hemolytic streptococci, and viridans 
group streptococci, but rare for gram-negative bacteria and 
coagulase-negative staphylococci; 1.3% of bacteremias caused by 
gram-negative bacteria resulted in a PJI. There were 11 PJIs as a 
consequence of bacteremia that occurred within 3 months of the 
previous surgery. These infections were caused by Staphylococcus 
aureus (n = 3), viridans group streptococci (n = 2), Streptococcus 
agalactiae (n  =  2), Clostridium perfringens (n  =  2), Klebsiella 
terrigena (n = 1), and group G streptococcus (n = 1).
Having more than 1 bacteremia during the study period 
increased the risk for developing a PJI (Table 2). Also, the risk for 
developing a PJI was higher for bacteremias occurring less than 
a year after the previous surgery than for bacteremias occurring 
later. Gender, obesity (BMI ≥  25), operated joint (hip, knee), 
indication for primary surgery, use of antibiotic-impregnated 
cement for prosthesis fixation, and chronic diseases did not 
Table 1. Distribution of Pathogens Causing Bacteremia and PJIs 
Developed During Bacteremias
Pathogen 
Total No. of 
Bacteremias 
(n = 643)
No. of 
Bacteremias 
With a PJI 
(n = 46)
No. % No. %
Escherichia coli 241 37 3 1
Staphylococcus aureus 105 16 21a 20
Beta-hemolytic streptococci 58 9 12 21
Streptococcus pneumoniae 43 7 2 5
Coagulase-negative staphylococci 28 4 0 0
Enterococci 28 4 1 4
Klebsiella species 27 4 1 4
Viridans group streptococci 25 4 4 16
Other gram-negative bacteriab 46 7 0 0
Anaerobes 20 3 2 10
Yeasts 3 0.5 0 0
Otherc 12 2 0 0
Polymicrobial 7 1 0 0
Abbreviation: PJI, periprosthetic joint infection.
aIncludes 1 bilateral infection, which is counted as 1.
bIncludes enterobacteriae, Pseudomonas species, Proteus species, Morganella morganii, 
Citrobacter species, Haemophilus influenzae, Serratia marcescens.
cIncludes lactobacilli, Listeria monocytogenes, Actinobaculum schaalii, Aerococcus urinae, 
Arcanobacterium pyogenes, Granulicatella adiacens.
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affect the risk of developing a PJI as a consequence of bacte-
remia (Table 2). Older age was associated with a lower risk of 
developing a PJI, but when the effect of bacteremias caused by 
E. coli was taken into account in a multivariable analysis, the ef-
fect of patients’ age was no longer statistically significant (odds 
ratio, 0.97; 95% confidence interval, 0.95–1.00).
DISCUSSION
This study shows that development of a PJI as a consequence of 
bacteremia is highly dependent on the type of pathogen causing 
the bacteremia. The risk was the highest in bacteremias caused 
by Staphylococcus aureus, beta-hemolytic streptococci, and 
viridans group streptococci and was associated with repeated 
episodes of bacteremia. On the other hand, the development 
of a PJI during bacteremia caused by gram-negative bacteria, 
especially E.  coli, and coagulase-negative staphylococci, was 
rare. Patients with a bacteremia occurring within 1 year of pre-
vious surgery had a higher risk of developing a PJI than those 
with bacteremias occurring later.
In the current study, 7% of the episodes of bacteremia resulted 
in the development of a PJI, corresponding to the rate described 
by Uçkay et  al. [14]. In their study, 6% (5/81) of bacteremias 
resulted in a PJI. Other studies examining the risk of developing 
a PJI during SAB [18–22] have reported slightly higher rates 
than in the current study. Uçkay et al. reported a rate of 2.9% 
for PJI during bacteremia caused by E. coli, 14% for SAB, and 
40% for anaerobic bacteremia, but the number of PJIs as a con-
sequence of bacteremia was so small (n = 5) that it is difficult to 
make meaningful conclusions from the results. No other studies 
have examined the risk of developing a PJI during bacteremia 
caused by pathogens other than S. aureus.
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Figure 2. A, The distribution of periprosthetic infections over time in patients without bacteremia. B, The distribution over time of periprosthetic joint infections as a con-
sequence of bacteremia.
D
ow
nloaded from
 https://academ
ic.oup.com
/ofid/article-abstract/6/6/ofz218/5486406 by Tam
pere university library user on 27 Septem
ber 2019
PJIs as a Consequence of Bacteremia • ofid • 5
Interestingly, the risk of PJI was similar for bacteremias caused 
by Staphylococcus aureus and beta-hemolytic streptococci. 
However, it is not surprising, as streptococci have been reported 
to cause a considerable proportion of late hematogenous PJIs 
[1, 2, 16]. On the other hand, there were no PJIs during bacte-
remia caused by coagulase-negative staphylococci, even though 
they are significant pathogens that cause PJIs [1]. Coagulase-
negative staphylococcal bacteremias are mostly nosocomial 
[28], and it has been shown that nosocomial SABs are not as-
sociated with PJIs [20, 21], making it likely that this is the case 
for coagulase-negative staphylococci as well. Unfortunately, the 
differentiation between community-acquired and nosocomial 
bacteremias was not possible in this study. Despite the com-
monness of urosepsis caused by E. coli, especially in the oldest 
age groups, it rarely leads to the development of a PJI. Thus, 
patients with bacteremia caused by gram-negative bacteria do 
not warrant the special attention with respect to the develop-
ment of a PJI paid to those with bacteremias caused by S. aureus 
or beta-hemolytic streptococci.
This study demonstrates that viridans group streptococci can 
lead to the development of a hematogenous PJI, even though 
the absolute number was low. These bacteria are associated with 
dental or gastrointestinal sources [29, 30]. Unfortunately, due 
to the retrospective nature of the current study, patients’ dental 
status or previous dental procedures with or without antibiotic 
prophylaxis could not be evaluated, and thus conclusions on the 
risk for PJI after dental procedures could not be made.
No patient-related risk factors for the development of a PJI 
during bacteremia, such as chronic diseases, could be identified, 
and this has been the case in previous studies as well [14, 20]. 
However, having more than 2 bacteremias during the study 
period increased the risk of developing a PJI during bacteremia. 
This possibly reflects some unidentifiable factor that increased 
patients’ susceptibility to infection in general. Patients’ use of 
immunosuppressive medication was not evaluated, but rheu-
matic diseases did not increase the risk for developing a PJI 
during bacteremia, nor did diabetes. An important observation, 
instead, is that the risk for developing a PJI as a consequence of 
bacteremia was highest for bacteremias occurring within 1 year 
of previous surgery. Large studies have shown that the overall 
risk of developing a PJI is highest for the first 2 years after sur-
gery [7–9], and this is probably partly due to the increased risk 
for hematogenous PJIs. On the other hand, in a study by Rakow 
et  al., most of the hematogenous PJIs occurred after 2  years 
from primary surgery [13].
There are some limitations to this study. First, some of the 
patients could have had joint replacement surgery performed 
elsewhere, before the study period began, and thus all prosthetic 
joints at risk for infection could not be identified. In addition, 
there might have been other patients in the Pirkanmaa hos-
pital district with joint replacements inserted at other hospitals 
who developed PJIs during bacteremia, but they could not 
be identified, and this might have resulted in lower incidence 
numbers. However, as the number of patients with surgery 
performed elsewhere was probably not very high, its effect can 
be assumed to be insignificant. Second, due to the retrospective 
nature of this study, some of the data, such as dental procedures, 
were not available. To avoid other limitations related to retro-
spective data collection, such as missing PJI cases, multiple data 
sources were used. In addition, the source of bacteremia could 
not be investigated, and differentiation between recurrent and 
relapsing bacteremia was not possible in cases with multiple 
Table 2. Potential Risk Factors for Developing a Periprosthetic Joint Infection During Bacteremia
Risk Factor 
Joints With PJI 
(n = 47)
Joints Without 
PJI (n = 672)
Odds Ratio 95% Confidence Interval No. % No. %
No. of bacteremias ≥2 13 28 96 14 2.29 1.17–4.50
BMI ≥25 kg/m2 38 81 473 70 1.82 0.70–4.72
Chronic lung disease 3 6 33 5 1.32 0.39–4.48
Chronic heart disease 6 13 72 11 1.22 0.50–2.97
Male gender 21 45 276 41 1.16 0.64–2.10
Knee joint 29 62 398 59 1.11 0.60–2.04
Time since previous joint replacement, ya       
 <1 17 36 94 12 1.00  
 1–10 28 60 672 85 0.23 0.12–0.44
 >10 2 4 24 3 0.46 0.10–2.13
Age at the time of bacteremia, mean (SD),a y 71 (11) 76 (10) 0.97 0.94–0.99
Rheumatic disease 3 6 59 9 0.71 0.21–2.35
Diabetes 5 11 103 15 0.66 0.25–1.70
Primary osteoarthritis as indication for primary joint replacement 43 92 588 88 0.65 0.23–1.86
Use of antibiotic-loaded cement in the primary operation 35 74 555 83 0.59 0.30–1.17
Abbreviations: BMI, body mass index; PJI, periprosthetic joint infection.
aCalculated for each bacteremia and joint (n = 837) separately.
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episodes of bacteremia. Third, it is impossible to say with ab-
solute certainty whether all PJIs attributed to bacteremia were 
truly so, but patient charts were reviewed carefully to minimize 
this error. The pathogens causing the early PJIs during bacte-
remia were not typical pathogens causing primary PJIs, thus 
supporting the fact that these PJIs were truly consequent to the 
bacteremia. Finally, as there was a limited follow-up period for 
each joint (maximum 12 years), PJIs as a consequence of bacte-
remia occurring after the study period were missed, thus poten-
tially affecting the incidence numbers.
In conclusion, this large study shows that the type of path-
ogen, history of infections, and timing of bacteremia should 
be taken into account when evaluating the risk of PJI in a pa-
tient with bacteremia. Developing a PJI during an episode of 
bacteremia caused by Stapylococcus aureus or beta-hemolytic 
streptococci is fairly common, and viridans group streptococci 
can lead to PJIs during bacteremia. This should be taken into 
account when a patient with a joint replacement presents with 
bacteremia caused by these agents, especially during the first 
postoperative year. Although diabetes, rheumatoid arthritis, 
and chronic heart and lung diseases did not affect the risk of PJI, 
there is possibly some unknown factor that increases patients’ 
susceptibility to infection in general and thus also to developing 
a PJI during bacteremia.
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